Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mainz Biomed B.V. (MYNZ)
NASDAQ:MYNZ
Holding MYNZ?
Track your performance easily
MYNZ Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.65 - $48.80
Previous CloseN/A
Volume20.13K
Average Volume (3M)135.18K
Market Cap
$10.33M
Enterprise ValueN/A
Total Cash (Recent Filing)$203.59K
Total Debt (Recent Filing)$787.62K
Price to Earnings (P/E)―
Beta0.78
Next Earnings
Apr 15, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-65.57
Shares Outstanding2,221,597
10 Day Avg. Volume98,099
30 Day Avg. Volume135,183
Standard Deviation0.22
R-Squared0.00247
Alpha-0.09
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)43.30
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
Mainz Biomed B.V. News
PremiumCompany Announcements
Mainz Biomed B.V. Addresses Nasdaq Listing Compliance Issue
PremiumCompany Announcements
Mainz Biomed Secures $8 Million in Follow-On Offering
Ownership Overview
―
Insiders
0.68%
Mutual Funds
― Other Institutional Investors
99.32% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
MYNZ FAQ
What was Mainz Biomed B.V.’s price range in the past 12 months?
Mainz Biomed B.V. lowest stock price was $3.65 and its highest was $48.80 in the past 12 months.
What is Mainz Biomed B.V.’s market cap?
Mainz Biomed B.V.’s market cap is $10.33M.
When is Mainz Biomed B.V.’s upcoming earnings report date?
Mainz Biomed B.V.’s upcoming earnings report date is Apr 15, 2025 which is in 87 days.
How were Mainz Biomed B.V.’s earnings last quarter?
Currently, no data Available
Is Mainz Biomed B.V. overvalued?
According to Wall Street analysts Mainz Biomed B.V.’s price is currently Overvalued.
Does Mainz Biomed B.V. pay dividends?
Mainz Biomed B.V. does not currently pay dividends.
What is Mainz Biomed B.V.’s EPS estimate?
Mainz Biomed B.V.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mainz Biomed B.V. have?
Mainz Biomed B.V. has 2,221,597 shares outstanding.
What happened to Mainz Biomed B.V.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Mainz Biomed B.V.?
Currently, no hedge funds are holding shares in MYNZ
---
Company Description
Mainz Biomed B.V.
Mainz Biomed BV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. It's main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results.
---
MYNZ Stock 12 Month Forecast
Average Price Target
―Technical Analysis
T2 Biosystems
―
Relmada Therapeutics
―
SELLAS Life Sciences Group
―
Exicure
―
Cellectar Biosciences
―
Gilead Sciences
―
Best Analysts Covering MYNZ
1 Year
1 Year Success Rate
0/8 ratings generated profit
1 Year Average Return
-85.94%
reiterated a buy rating 8 months ago
Copying Justin Walsh's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -85.94% per trade.
---